NAVIGATING ANTIBODY-DRUG CONJUGATE TARGETS EXPRESSION PROFILES ACROSS DIVERSE PROSTATE CANCER TYPES

被引：0
|
作者：
Mulati, Yelin
Fan, Yu
Tian, Yuxuan
Yao, Kaifeng
Shen, Qi
Yu, Wei
Zhang, Qian
He, Zhisong
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD42-09
引用
收藏
页码：E896 / E896
页数：1
相关论文
共 50 条
  • [41] MONOCLONAL ANTIBODY-DRUG CONJUGATE THERAPY FOR THE PATIENTS WITH COLORECTAL-CANCER
    TAKAHASHI, T
    YAMAGUCHI, T
    KITAMURA, K
    NOGUCHI, A
    HONDA, M
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02): : 371 - 374
  • [42] Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
    Park, Jong Chul
    Shin, Donghoon
    JCO PRECISION ONCOLOGY, 2024, 8
  • [43] Development of an antibody-drug conjugate against tissue factor for cancer therapy
    Tsumura, Ryo
    Anzai, Takahiro
    Takashima, Hiroki
    Koga, Yoshikatsu
    Matsumura, Yasuhiro
    Yasunaga, Masahiro
    CANCER SCIENCE, 2024, 115 : 617 - 617
  • [44] Efficacy Studies of an Antibody-Drug Conjugate PSMA-ADC in Patient-Derived Prostate Cancer Xenografts
    DiPippo, Vincent A.
    Olson, William C.
    Nguyen, Holly M.
    Brown, Lisha G.
    Vessella, Robert L.
    Corey, Eva
    PROSTATE, 2015, 75 (03): : 303 - 313
  • [45] Sequencing Antibody-Drug Conjugate after Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 study): Multi-Institution Experience and Biomarker Analysis
    Abelman, Rachel Occhiogrosso
    Spring, Laura
    Fell, Geoffrey
    Davis, Andrew
    Hensing, Whitney
    Ryan, Phoebe
    Vidula, Neelima
    Wander, Seth
    Medford, Arielle
    Shin, Jennifer
    Abraham, Elizabeth
    Isakoff, Steven
    Moy, Beverly
    Ellisen, Leif
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [46] Evaluation of Quantitative Relationship Between Target Expression and Antibody-Drug Conjugate Exposure Inside Cancer Cells
    Sharma, Sharad
    Li, Zhe
    Bussing, David
    Shah, Dhaval K.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (05) : 368 - 377
  • [47] Sequencing Antibody-Drug Conjugate After Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 Study): Multi-institution Experience and Biomarker Analysis
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01)
  • [48] Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs
    Tang, Qi
    Li, Hui
    Zhao, Xin Tong
    Li, Ze Ying
    Ma, Chun Xiao
    Zhou, Shao Qiang
    Chen, De Dian
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (04) : 527 - 542
  • [49] Navigating the future of gastric cancer treatment: a review on the impact of antibody-drug conjugates
    Yin, Qingling
    Zhang, Yanlong
    Xie, Xueqing
    Hou, Meijun
    Chen, Xunsheng
    Ding, Jie
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [50] Comparative analysis of the expression of clinically available contemporary antibodydrug conjugate targets in varied prostate cancer types
    Mulati, Y.
    Fan, Y.
    Tian, Y.
    Yao, K.
    Shen, Q.
    Yu, W.
    Zhang, Q.
    He, Z.
    EUROPEAN UROLOGY, 2024, 85 : S332 - S332
12345